Education
About Us
Working with TipRanks
Follow Us
Fortrea Holdings Inc. (FTRE)
NASDAQ:FTRE
FTRE Stock Chart & Stats
$11.18
-$0.82(-4.27%)
At close: 4:00 PM EST
$11.18
-$0.82(-4.27%)
Day’s Range― - ―
52-Week Range$3.97 - $25.28
Previous CloseN/A
Volume188.47K
Average Volume (3M)1.27M
Market Cap
$1.04B
Enterprise Value$1.82B
Total Cash (Recent Filing)$131.30M
Total Debt (Recent Filing)$1.19B
Price to Earnings (P/E)―
Beta1.62
Next Earnings
Mar 16, 2026EPS Estimate
0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.12
Shares Outstanding92,400,000
10 Day Avg. Volume1,498,585
30 Day Avg. Volume1,266,561
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.23
Price to Sales (P/S)0.62
P/FCF Ratio7.03
Enterprise Value/Market Cap1.75
Enterprise Value/Revenue0.66
Enterprise Value/Gross Profit3.84
Enterprise Value/Ebitda-2.14
Forecast
1Y Price Target
$11.19Price Target Upside0.09% Upside
Rating ConsensusHold
Number of Analyst Covering10
EPS Forecast (FY)0.51
Revenue Forecast (FY)$2.72B
Bulls Say, Bears Say
Bulls Say
Financial PerformanceFortrea reported strong third-quarter results that featured sizable top- and bottom-line beats and significantly higher-than-expected net new business awards, which led to massive sequential improvement in its net book-to-bill ratio.
Revenue OutlookFortrea raised its revenue outlook for 2025 by $75 million, indicating confidence in future growth.
Strategic PartnershipsFTRE noted improving macro environment, especially in biotech, with new partner signings and a strong win rate.
Bears Say
Earnings PerformanceAdjusted earnings per share of $0.12 fell short of the $0.14 estimate, indicating a slight underperformance.
Future ChallengesFTRE's 2026 looks difficult, with weak B2B's and continued passthroughs likely contracting top-line and margins.
Margin PressureThe reintroduction of variable compensation is another margin headwind, and FTRE still sees a competitive pricing environment for FSP.
Fortrea Holdings Inc. News
FTRE FAQ
What was Fortrea Holdings Inc.’s price range in the past 12 months?
Fortrea Holdings Inc. lowest stock price was $3.97 and its highest was $25.28 in the past 12 months.
What is Fortrea Holdings Inc.’s market cap?
Fortrea Holdings Inc.’s market cap is $1.04B.
When is Fortrea Holdings Inc.’s upcoming earnings report date?
Fortrea Holdings Inc.’s upcoming earnings report date is Mar 16, 2026 which is in 124 days.
How were Fortrea Holdings Inc.’s earnings last quarter?
Fortrea Holdings Inc. released its earnings results on Nov 05, 2025. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.16 by -$0.04.
Is Fortrea Holdings Inc. overvalued?
According to Wall Street analysts Fortrea Holdings Inc.’s price is currently Undervalued.
Does Fortrea Holdings Inc. pay dividends?
Fortrea Holdings Inc. does not currently pay dividends.
What is Fortrea Holdings Inc.’s EPS estimate?
Fortrea Holdings Inc.’s EPS estimate is 0.17.
How many shares outstanding does Fortrea Holdings Inc. have?
Fortrea Holdings Inc. has 92,400,000 shares outstanding.
What happened to Fortrea Holdings Inc.’s price movement after its last earnings report?
Fortrea Holdings Inc. reported an EPS of $0.12 in its last earnings report, missing expectations of $0.16. Following the earnings report the stock price went up 23.196%.
Which hedge fund is a major shareholder of Fortrea Holdings Inc.?
Currently, no hedge funds are holding shares in FTRE
Fortrea Holdings Inc. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$11.19 (0.09% Upside)
$11.19 (0.09% Upside)
Blogger Sentiment
Bullish
FTRE Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 2.6M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $507.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ―
Last 30 Days ―
Last 30 Days ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-52.42%
12-Months-Change
Fundamentals
Return on Equity
-98.13%
Trailing 12-Months
Asset Growth
-25.15%
Trailing 12-Months
Company Description
Fortrea Holdings Inc.
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
FTRE Company Deck
FTRE Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a mix of positive developments such as revenue growth, improved book-to-bill ratio, and strong cash position, alongside challenges like decreased adjusted EBITDA and a competitive FSP pricing environment. The positive aspects, including strategic innovations and high client satisfaction, generally outweighed the negatives.View all FTRE earnings summariesFTRE Stock 12 Month Forecast
Average Price Target
$11.19
▲(0.09% Upside)
Technical Analysis
Nektar Therapeutics
―
Fulcrum Therapeutics
―
Compass Therapeutics
―
Erasca
―
Aura Biosciences Inc
―
Ownership Overview
0.53% Insiders
19.64% Mutual Funds
0.49% Other Institutional Investors
46.63% Public Companies and
Individual Investors